Arnold DL - Search Results

1

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.

Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group. Montalban X, et al. Among authors: arnold dl. N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10. N Engl J Med. 2019. PMID: 31075187 Clinical Trial.

2

The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis.

Arnold DL, Wolinsky JS, Matthews PM, Falini A. Arnold DL, et al. J Neurol Neurosurg Psychiatry. 1998 May;64 Suppl 1:S94-101. J Neurol Neurosurg Psychiatry. 1998. PMID: 9647294 Free article. Review.

3

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.

Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL. Matthews PM, et al. Among authors: arnold dl. Semin Neurol. 1998;18(3):327-36. doi: 10.1055/s-2008-1040884. Semin Neurol. 1998. PMID: 9817537 Review.

4

The lesions of multiple sclerosis.

Paty DW, Arnold DL. Paty DW, et al. Among authors: arnold dl. N Engl J Med. 2002 Jan 17;346(3):199-200. doi: 10.1056/NEJM200201173460311. N Engl J Med. 2002. PMID: 11796856 No abstract available.

5

MRI in the diagnosis and management of multiple sclerosis.

Arnold DL, Matthews PM. Arnold DL, et al. Neurology. 2002 Apr 23;58(8 Suppl 4):S23-31. doi: 10.1212/wnl.58.8_suppl_4.s23. Neurology. 2002. PMID: 11971123 Review.

6

Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.

Filippi M, Falini A, Arnold DL, Fazekas F, Gonen O, Simon JH, Dousset V, Savoiardo M, Wolinsky JS; White Matter Study Group. Filippi M, et al. Among authors: arnold dl. J Magn Reson Imaging. 2005 Jun;21(6):669-75. doi: 10.1002/jmri.20336. J Magn Reson Imaging. 2005. PMID: 15906322 Review.

7

Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

Simon JH, Li D, Traboulsee A, Coyle PK, Arnold DL, Barkhof F, Frank JA, Grossman R, Paty DW, Radue EW, Wolinsky JS. Simon JH, et al. Among authors: arnold dl. AJNR Am J Neuroradiol. 2006 Feb;27(2):455-61. AJNR Am J Neuroradiol. 2006. PMID: 16484429 Free PMC article. No abstract available.

8

EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.

Filippi M, Rocca MA, Arnold DL, Bakshi R, Barkhof F, De Stefano N, Fazekas F, Frohman E, Wolinsky JS. Filippi M, et al. Among authors: arnold dl. Eur J Neurol. 2006 Apr;13(4):313-25. doi: 10.1111/j.1468-1331.2006.01543.x. Eur J Neurol. 2006. PMID: 16643308

9

Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.

Bar-Or A, Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, Gianettoni J, Jalili F, Kachuck N, Lapierre Y, Niino M, Oger J, Price M, Rhodes S, Robinson WH, Shi FD, Utz PJ, Valone F, Weiner L, Steinman L, Garren H. Bar-Or A, et al. Among authors: arnold dl. Arch Neurol. 2007 Oct;64(10):1407-15. doi: 10.1001/archneur.64.10.nct70002. Epub 2007 Aug 13. Arch Neurol. 2007. PMID: 17698695 Clinical Trial.

10

Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.

Sajja BR, Narayana PA, Wolinsky JS, Ahn CW; PROMiSe Trial MRSI Group. Sajja BR, et al. Mult Scler. 2008 Jan;14(1):73-80. doi: 10.1177/1352458507079907. Epub 2007 Sep 19. Mult Scler. 2008. PMID: 17881390 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

530 results

Search Page